Advisory Research’s Medpace MEDP Stock Holding History

Advisory Research’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,832	Closed	-$1.48M	–	258
2023 Q4	$1.48M	Sell	4,832 -3,284	-40%	-$886K	0.23%	118
2023 Q3	$1.97M	Buy	8,116 +3,896	+92%	+$996K	0.27%	105
2023 Q2	$1.01M	Buy	+4,220	New	+$877K	0.13%	201

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Advisory Research's MEDP Position: Q1 2024 in Review

Advisory Research sold out of Medpace (MEDP) in Q1 2024, closing a stake of 4,832 shares — an estimated $1.48M sold.

Advisory Research first reported a position in MEDP in Q2 2023 and held it in 3 quarters. The position peaked at $1.97M in Q3 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

Advisory Research reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
Advisory Research sold 4,832 Medpace shares in Q1 2024, an estimated $1.48M.
Advisory Research first reported a position in Medpace in Q2 2023 and held it in 3 quarters.
Advisory Research's Medpace position peaked at $1.97M in Q3 2023.
597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.